ReviewDiscover oncology2025
Regulation of GLI2 by LINC02560 and its role in hepatocellular carcinoma.
Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This article focuses on the regulation of GLI2 by LINC02560 in HCC. Revealing this mechanism provides a new perspective for the morbidity mechanism and treatment strategy of hepatocellular carcinoma.LINC02560, a long non-coding RNA (lncRNA), is upregulated in hepatocellular carcinoma through interaction with GLI2 protein. They jointly regulate key biological processes such as cell proliferation, invasion, migration and apoptosis. It was found that LINC02560 not only directly binds to GLI2 protein, It also plays a regulatory role by affecting the epigenetic modification of GLI2 gene and the interaction with other transcription factors. These mechanisms contribute to the initiation and progression of HCC. In addition, the expression level of LINC02560 is closely related to the therapeutic effect and prognosis of hepatocellular carcinoma. It provides an important basis for the formulation of individualized treatment plan. Therefore, the study of GLI2 regulation by LINC02560 not only deepens our understanding of the mechanism of morbidity in hepatocellular carcinoma, It also provides important clues for finding new therapeutic targets and improving therapeutic effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.